Inventor · disambiguated record
Dan Niculescu-Duvaz
Also filed as: NICULESCU-DUVAZ DAN · NICULESCU-DUVAZ DAN M
26 granted patents·2 pending applications·270 citations·filing 2002–2022
96Inventor score
Files withCANCER REC TECH LTD7THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL7CANCER RESEARCH TECH LTD4CANCER RES TECH LTD3CANCER RES INST ROYAL2
Top patents by PatentIndex Score
28 records- 0197US6916949B2Methods of chemical systhesis of phenolic nitrogen mustard prodrugsCANCER REC TECH LTD·Filed 2002·Granted Jul 12, 2005·62 cites·54 claims
- 0294US7951819B2Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compoundsCANCER REC TECH LTD·Filed 2007·Granted May 31, 2011·37 cites·46 claims
- 0390US8198279B2Pyrido[2,3-b]pyrazin-8-substituted compounds and their useSPRINGER CAROLINE JOY·Filed 2008·Granted Jun 12, 2012·18 cites·34 claims
- 0489US7235585B2Enzyme activated self-immolative n-substituted nitrogen mustard prodrugsCANCER REC TECH LTD·Filed 2003·Granted Jun 26, 2007·58 cites·53 claims
- 0588US10995088B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2020·Granted May 4, 2021·2 cites·22 claims
- 0688US9120789B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER REC TECH LTD·Filed 2014·Granted Sep 1, 2015·7 cites·39 claims
- 0787US9155737B2Pyrido[2,3-B]pyrazin-8-substituted compounds and their useCANCER RES INST ROYAL·Filed 2014·Granted Oct 13, 2015·8 cites·33 claims
- 0887US8912191B2Pyrido[2,3-B]pyrazin-8-substituted compounds and their useCANCER REC TECH LTD·Filed 2013·Granted Dec 16, 2014·8 cites·20 claims
- 0987US8546387B2Pyrido[2,3-b]pyrazin-8-substituted compounds and their useSPRINGER CAROLINE JOY·Filed 2012·Granted Oct 1, 2013·11 cites·32 claims
- 1087US8383816B2Aryl-quinolyl compounds and their useCANCER REC TECH LTD·Filed 2009·Granted Feb 26, 2013·13 cites·29 claims
- 1186US7625922B2Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compoundsCANCER REC TECH LTD·Filed 2005·Granted Dec 1, 2009·19 cites·44 claims
- 1285US9725447B21-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancerCANCER RES TECH LTD·Filed 2014·Granted Aug 8, 2017·8 cites·45 claims
- 1385US9439893B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER RES TECH LTD·Filed 2015·Granted Sep 13, 2016·4 cites·29 claims
- 1482US8815896B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapySPRINGER CAROLINE·Filed 2011·Granted Aug 26, 2014·7 cites·33 claims
- 1581US9708317B2Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivativesCANCER RES TECH LTD·Filed 2014·Granted Jul 18, 2017·2 cites·83 claims
- 1680US10807974B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2017·Granted Oct 20, 2020·2 cites·35 claims
- 1775US9820976B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER RESEARCH TECH LTD·Filed 2016·Granted Nov 21, 2017·1 cites·30 claims
- 1873US11325915B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2018·Granted May 10, 2022·1 cites·18 claims
- 1969US9540372B2Pyrido[2,3-b]pyrazin-8-substituted compounds and their useINST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)·Filed 2015·Granted Jan 10, 2017·1 cites·37 claims
- 2065US11608330B2Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancerTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2021·Granted Mar 21, 2023·0 cites·34 claims
- 2164US12060360B2Lysyl oxidase inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2022·Granted Aug 13, 2024·0 cites·16 claims
- 2258US9193689B23-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic useCANCER RES INST ROYAL·Filed 2013·Granted Nov 24, 2015·1 cites·30 claims
- 2357US10100053B2Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivativesCANCER RESEARCH TECH LTD·Filed 2017·Granted Oct 16, 2018·0 cites·2 claims
- 2450US2024174634A1Aldehyde Dehydrogenase Inhibitors and Their Therapeutic UseCANCER RESEARCH TECH LTD·Filed 2021·Application pending·0 cites
- 2548US10167282B21-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancerCANCER RESEARCH TECH LTD·Filed 2017·Granted Jan 1, 2019·0 cites·26 claims
- 2643US2022017516A1Lox inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Application pending·0 cites
- 2740US12018029B2Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitorsTHE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL·Filed 2019·Granted Jun 25, 2024·0 cites·19 claims
- 2834US9611223B23-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic useINST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)·Filed 2014·Granted Apr 4, 2017·0 cites·33 claims
Join the waitlist — get patent alerts
Get an alert when Dan Niculescu-Duvaz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →